Stanford University
Showing 20,731-20,740 of 36,180 Results
-
Arnav Mehta, MD, PhD
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDr. Mehta is a board-certified, fellowship-trained medical oncologist at the Stanford Medicine Cancer Center. He is also an adjunct clinical assistant professor in the gastrointestinal (GI) oncology group of the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Mehta specializes in gastrointestinal cancer, with a particular focus on pancreatic and gastric cancers. He also treats colorectal cancers. His treatment specialties include immunotherapy — helping a patient’s immune system fight cancer — and targeted therapies, which send cancer-fighting drugs to specific cancer cell molecules.
His research interests include understanding why GI cancers resist treatments and identifying new ways to treat these tumors. In particular, he is interested in GI tumor immunology, which focuses on directing a person’s immune system to help destroy cancer cells. He also has a special interest in tumor plasticity, which represents the ability of a tumor cell to evolve and develop resistance to therapies.
Dr. Mehta has earned research awards and grants from organizations including the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and the National Institutes of Health.
Dr. Mehta has published in many peer-reviewed journals, including Nature, Nature Genetics, Nature Immunology, Nature Medicine, Nature Cancer, Cancer Discovery and Immunity. He has written book chapters on subjects including esophageal and gastric cancer. He has also presented his research on topics including tumor immunology and pancreatic cancer at dozens of symposia and meetings around the country.
Dr. Mehta is a member of the AACR and ASCO. -
Krish Mehta
Affiliate, Graduate School of Business - Center for Entrepreneurial Studies
BioPassionate about cleantech / climate entrepreneurship. Previously, manager for Model 3 program at Tesla, and Engagement manager at McKinsey's Sustainability practice.
-
Niraj Mehta
MBA, expected graduation 2027
Current Research and Scholarly InterestsPlants provide some of the most important drugs in current clinical use. It can be challenging to chemically synthesize these drugs or sustainably source them from producer plants. These issues could be alleviated if their biosynthetic genes are engineered into heterologous organisms for large-scale production. I am interested in a) understanding how plants produce these valuable drugs and b) engineering the sustainable production of these drugs into other plants for large-scale production.
